Immunosuppressive approaches to the prevention of graft vascular disease.
Gregory
C R
CR
Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis 95616, USA.
D003327:Coronary Disease / Q000276:immunology / Q000517:prevention & control*; D016572:Cyclosporine / Q000627:therapeutic use; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007555:Isoxazoles / Q000627:therapeutic use; D000077339:Leflunomide; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011090:Polyenes / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control*; D020123:Sirolimus; D016559:Tacrolimus / Q000627:therapeutic use
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D011090:Polyenes; D016572:Cyclosporine; D000077339:Leflunomide; D009173:Mycophenolic Acid; D020123:Sirolimus; D016559:Tacrolimus